Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Testosterone boosts red blood cell production and changes iron metabolism without needing dihydrotestosterone.

Blocking a specific enzyme in male rat fetuses leads to the development of nipples and feminized genitalia.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

The 0.25% finasteride solution, when applied once a day, effectively reduces scalp DHT, potentially minimizing sexual side-effects linked to a systemic DHT reduction.

MK-386 lowers DHT in blood and skin but not in semen.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

DHT deficiency in rats reduces sperm content and affects testis structure over time.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

DHT deficiency increases iNOS expression in rat testis and epididymis.

The normal human prostate does not significantly affect blood DHT levels.

Male cells need DHT to respond to testosterone, while female cells do not.

Finasteride changes androgen receptor location in rat epididymis without altering tissue structure.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

DHT stops hair regrowth in mice, similar to human hair loss.

Dihydrotestosterone affects hair growth by changing the Wnt/β-catenin pathway, with low levels helping and high levels hindering growth.

Ginsenoside F2 may help prevent hair loss and promote hair growth better than finasteride.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

High levels of testosterone and dihydrotestosterone inhibit hair cell growth, while high levels of estradiol promote it.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.